Investigation reveals Croton penduliflorus demonstrates significant anthelmintic activity against Eudrilus eugeniae, suggesting potential for novel treatments.
The growing resistance to anthelmintic drugs highlights the urgent need for new, plant-derived therapeutics. This study investigates the synergistic anthelmintic activity of Croton penduliflorus stem bark extracts. Soxhlet extraction yielded 3.06% from the stem bark, with phytochemical screening revealing sterols as dominant constituents. The stem bark extract showed strong activity against Eudrilus eugeniae, causing paralysis and death within 8 ± 0.6 and 15 ± 0.5 min respectively at 100 mg/mL, with the ethyl acetate fraction being the most potent. GC–MS profiling identified key bioactive phytoconstituents including hexadecanamide, oleamide, and 1-heptacosanol—compounds known to disrupt membrane integrity, induce oxidative stress, and interfere with neuromuscular function. Molecular docking showed moderate binding affinity to β-tubulin, while molecular dynamics simulations revealed short-lived protein-ligand interactions, suggesting a non-exclusive tubulin targeting mechanism. The rapid anthelmintic response, combined with effects among fatty acid amides, sterols, and phenolics, suggests a multifactorial mode of action. These results support the traditional use of C. penduliflorus and underscore its stem bark as a promising source of synergistically acting lead compounds for novel anthelmintic drug development.
No takes yet. Share an insight, caveat, or question.
Owusu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: